113 related articles for article (PubMed ID: 9744351)
1. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
[TBL] [Abstract][Full Text] [Related]
2. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
3. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
[TBL] [Abstract][Full Text] [Related]
4. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
5. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.
Ohtomo K; Terui S; Yokoyama R; Abe H; Terauchi T; Maeda G; Beppu Y; Fukuma H
J Nucl Med; 1996 Sep; 37(9):1444-8. PubMed ID: 8790189
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.
Wakabayashi H; Taki J; Inaki A; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
Clin Nucl Med; 2012 Jan; 37(1):1-8. PubMed ID: 22157020
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
8. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
9. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
Ramanna L; Waxman A; Binney G; Waxman S; Mirra J; Rosen G
J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
[TBL] [Abstract][Full Text] [Related]
10. Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.
Ilhan IE; Vural G; Berberoglu S; Kapucuoglu N; Cila A; Eke S
Pediatr Hematol Oncol; 2005 Mar; 22(2):153-62. PubMed ID: 15805001
[TBL] [Abstract][Full Text] [Related]
11. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
12. Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma.
Inaki A; Taki J; Wakabayashi H; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
Ann Nucl Med; 2012 Aug; 26(7):545-50. PubMed ID: 22610389
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.
Yamamoto Y; Nishiyama Y; Satoh K; Takashima H; Ohkawa M; Fujita J; Kishi T; Matsuno S; Tanabe M
J Nucl Med; 1998 Sep; 39(9):1626-9. PubMed ID: 9744357
[TBL] [Abstract][Full Text] [Related]
14. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
[TBL] [Abstract][Full Text] [Related]
15. Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99m MIBI imaging in bone and soft tissue sarcomas.
Taki J; Inaki A; Wakabayashi H; Sumiya H; Tsuchiya H; Zen Y; Kinuya S
Clin Nucl Med; 2010 Mar; 35(3):154-9. PubMed ID: 20173444
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
[TBL] [Abstract][Full Text] [Related]
17. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
Sato O; Kawai A; Ozaki T; Kunisada T; Danura T; Inoue H
J Orthop Sci; 1998; 3(6):297-303. PubMed ID: 9811980
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
[TBL] [Abstract][Full Text] [Related]
19. The role of thallium-201 uptake and retention in intracranial tumors after radiotherapy.
Lorberboym M; Mandell LR; Mosesson RE; Germano I; Lou W; DaCosta M; Linzer DG; Machac J
J Nucl Med; 1997 Feb; 38(2):223-6. PubMed ID: 9025741
[TBL] [Abstract][Full Text] [Related]
20. Comparison of differential diagnostic capabilities of 201Tl scintigraphy and fine-needle aspiration of thyroid nodules.
Okumura Y; Takeda Y; Sato S; Komatsu M; Nakagawa T; Akaki S; Kuroda M; Joja I; Hiraki Y
J Nucl Med; 1999 Dec; 40(12):1971-7. PubMed ID: 10616873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]